ID 202191797 · FY 2017–2024 · 8 years
Medpharma Plus (მედფარმა პლუსი, medpharma.ge) — a specialized retail pharmacy in Tbilisi (76 Uznadze St.) focused on imported cardiovascular medicines, anticoagulants and blood-pressure devices (tonometers). Its higher-than-typical gross margin reflects self-imported niche products; active and growing through FY2024.
curated 2026-06-25
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,289 | 3,481 | 3,518 | 3,769 | 3,134 | 5,008 | 4,488 | 4,916 | +5.9% |
| Total COGS | -1,768 | -1,599 | -1,598 | -1,807 | -1,669 | -2,230 | -1,672 | -1,946 | +1.4% |
| Gross Profit | 1,521 | 1,882 | 1,919 | 1,962 | 1,466 | 2,778 | 2,817 | 2,970 | +10.0% |
| Gross Margin | 46.2% | 54.1% | 54.6% | 52.0% | 46.8% | 55.5% | 62.8% | 60.4% | |
| Total Operating Expenses | -266 | -1,022 | -1,146 | -1,203 | -1,128 | -1,496 | -1,768 | -1,847 | +31.9% |
| EBITDA | 1,255 | 859 | 773 | 758 | 338 | 1,282 | 1,049 | 1,123 | -1.6% |
| EBITDA Margin | 38.2% | 24.7% | 22.0% | 20.1% | 10.8% | 25.6% | 23.4% | 22.8% | |
| Total D&A | -83 | -79 | -147 | -144 | -129 | -168 | -208 | -218 | +14.9% |
| EBIT / Operating Income | 1,173 | 780 | 626 | 615 | 209 | 1,115 | 840 | 905 | -3.6% |
| Total Interest Income | 0 | 0 | 0 | 27 | 43 | 10 | 27 | 76 | +28.9% |
| Total Interest Expense | -9 | -2 | -8 | -4 | -15 | -16 | -23 | -5 | -8.1% |
| Total Other Income | -27 | 47 | -56 | 109 | 788 | -169 | 59 | 40 | nmf |
| Profit Before Tax | 1,136 | 825 | 562 | 747 | 1,025 | 939 | 903 | 1,016 | -1.6% |
| Total Income Tax | 0 | -0 | -0 | -17 | -53 | -64 | -95 | -75 | nmf |
| Net Profit / (Loss) | 555 | 825 | 561 | 730 | 972 | 875 | 808 | 940 | +7.8% |
| Net Margin | 16.9% | 23.7% | 16.0% | 19.4% | 31.0% | 17.5% | 18.0% | 19.1% |
Ownership & directors from companyinfo.ge (public corporate registry).